Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Heterologous type I collagen** is a purified collagen product derived from non-human animal sources, commonly equine (horse) tendon, and used for biomedical, pharmaceutical, and cosmetic applications, primarily as a regenerative biomaterial and injectable medical device[1][3][4]. It acts as a substrate for cell adhesion, growth, and differentiation of connective tissue cells, promoting fibroblast proliferation, extracellular matrix (ECM) reconstruction, and facilitating physiological neoformation of human collagen. Its main clinical applications include the management of skin aging (biorevitalization), treatment of connective tissue injuries, and as an adjunct in therapies for disorders such as vitiligo, where it may enhance repigmentation by stimulating melanogenesis and ECM repair[3][4]. Products such as Linerase use sterile, pyrogen-free equine-derived type I collagen for intradermal injections, typically administered by healthcare professionals in protocols that include repeated sessions[3]. Mechanistically, it supports tissue regeneration, modulates local inflammatory response, and provides a scaffold for new ECM synthesis[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on heterologous type I collagen.